A Chinese city has taken on pharmaceutical companies and local doctors in the battle against healthcare cost inflation — and is now being touted as a nationwide model.
Health spending in China tripled in the decade to 2014, outpacing income growth, as an ageing population became more susceptible to chronic diseases and hospitals have made up for shortfalls in public funding by selling branded drugs at steep mark-ups.
As state-funded healthcare insurance is limited, patients pay more than a third of medical costs from their own money. China’s average life expectancy rose by three years to 76 over the same period.
您已阅读11%（617字），剩余89%（4842字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。